IMBRIANO, Carol
 Distribuzione geografica
Continente #
NA - Nord America 11.855
AS - Asia 6.349
EU - Europa 5.773
SA - Sud America 927
AF - Africa 146
OC - Oceania 80
Continente sconosciuto - Info sul continente non disponibili 4
Totale 25.134
Nazione #
US - Stati Uniti d'America 11.606
SG - Singapore 2.008
IT - Italia 1.942
CN - Cina 1.604
GB - Regno Unito 1.261
HK - Hong Kong 766
BR - Brasile 707
VN - Vietnam 697
SE - Svezia 652
DE - Germania 391
BD - Bangladesh 301
FR - Francia 284
FI - Finlandia 239
RU - Federazione Russa 236
KR - Corea 183
UA - Ucraina 175
IN - India 166
ID - Indonesia 122
TR - Turchia 114
CA - Canada 103
JP - Giappone 95
MX - Messico 93
AR - Argentina 84
NL - Olanda 80
AU - Australia 79
BG - Bulgaria 71
ES - Italia 71
CZ - Repubblica Ceca 64
BE - Belgio 51
ZA - Sudafrica 50
PL - Polonia 44
IE - Irlanda 42
IQ - Iraq 41
LT - Lituania 40
EC - Ecuador 34
AE - Emirati Arabi Uniti 27
AT - Austria 27
CO - Colombia 26
UZ - Uzbekistan 25
MY - Malesia 24
PK - Pakistan 24
EG - Egitto 22
MA - Marocco 22
CH - Svizzera 20
SA - Arabia Saudita 20
CL - Cile 19
PH - Filippine 17
VE - Venezuela 17
TW - Taiwan 15
PY - Paraguay 14
UY - Uruguay 14
CR - Costa Rica 11
DZ - Algeria 11
TH - Thailandia 11
TN - Tunisia 11
IL - Israele 10
IR - Iran 10
NP - Nepal 10
PT - Portogallo 10
ET - Etiopia 9
JO - Giordania 9
KE - Kenya 9
LB - Libano 9
PE - Perù 9
AL - Albania 8
RS - Serbia 8
GR - Grecia 7
JM - Giamaica 7
RO - Romania 6
SI - Slovenia 6
AZ - Azerbaigian 5
BY - Bielorussia 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
NI - Nicaragua 5
SN - Senegal 5
BB - Barbados 4
EE - Estonia 4
GE - Georgia 4
HR - Croazia 4
HU - Ungheria 4
KZ - Kazakistan 4
LV - Lettonia 4
PA - Panama 4
PR - Porto Rico 4
AM - Armenia 3
BH - Bahrain 3
BO - Bolivia 3
CI - Costa d'Avorio 3
EU - Europa 3
HN - Honduras 3
KG - Kirghizistan 3
KW - Kuwait 3
LK - Sri Lanka 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
BZ - Belize 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
Totale 25.106
Città #
Ashburn 1.317
Singapore 1.228
Santa Clara 1.093
Fairfield 1.059
Southend 758
Hong Kong 740
Woodbridge 658
Chandler 594
San Jose 518
Hefei 512
Houston 446
Seattle 393
Ann Arbor 384
Modena 367
Cambridge 355
Wilmington 344
Nyköping 303
Jacksonville 296
Beijing 281
Council Bluffs 280
Dearborn 256
Los Angeles 235
London 227
Ho Chi Minh City 214
New York 206
Milan 186
Bologna 173
Hanoi 171
The Dalles 166
Seoul 164
Helsinki 138
Chicago 134
San Diego 101
Jakarta 95
Reggio Emilia 91
Munich 81
Lauterbourg 79
Moscow 74
Shanghai 73
Tokyo 72
Princeton 70
São Paulo 68
Sofia 67
Buffalo 65
Eugene 59
Parma 59
Izmir 53
Bremen 51
Dallas 50
Orem 46
Brno 45
Dong Ket 45
Rome 44
Fremont 43
Phoenix 43
Salt Lake City 43
Brussels 41
Mexico City 41
Boardman 38
Turku 38
Da Nang 37
Frankfurt am Main 36
Warsaw 36
Columbus 35
Dublin 34
Montreal 33
Denver 32
Poplar 32
Brooklyn 30
Durham 29
Johannesburg 29
Redwood City 29
Chennai 28
Atlanta 27
Formigine 27
Mumbai 27
Toronto 27
Stockholm 26
Kent 25
Paris 25
Turin 25
Falls Church 24
Rio de Janeiro 24
Tampa 24
Tashkent 24
Amsterdam 23
Des Moines 23
Elk Grove Village 23
Haiphong 23
Baghdad 22
Naples 22
Norwalk 21
Belo Horizonte 20
Guangzhou 19
Medesano 19
Nuremberg 19
Brasília 17
Florence 16
Lappeenranta 16
Manchester 16
Totale 16.895
Nome #
Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy 444
Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters 433
An autoregulatory loop controls the expression of the transcription factor NF-Y 426
NF-YA splice variants have different roles on muscle differentiation 414
Potent Anti-Cancer Properties of Phthalimide-Based Curcumin Derivatives on Prostate Tumor Cells 410
NF-Y splice variants differentially affect skeletal myogenesis 407
Newly synthesized curcumin derivatives: crosstalk between chemico-physical properties and biological activity. 397
Curcumin derivatives and Aβ-fibrillar aggregates: An interactions’ study for diagnostic/therapeutic purposes in neurodegenerative diseases 397
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 395
A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response 385
Curcumin derivatives: molecular basis of their anti-cancer activity. 384
Direct non transcriptional role of NF-Y in DNA replication 384
Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells 375
Direct p53 transcriptional repression: In vivo analysis of CCAAT-containing G2/M promoters 369
Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase 368
Phosphorylation and alternative splicing of MEF2C, a dual switch function in muscle regeneration 364
Transcriptionally regulated and non-toxic delivery of the hyperactive Sleeping Beauty Transposase 363
NF-Y recruitment of TFIID, multiple interactions with histone fold TAF(II)s 361
bis-Dehydroxy-Curcumin Triggers Mitochondrial-Associated Cell Death in Human Colon Cancer Cells through ER-Stress Induced Autophagy. 352
NF-Y activates genes of metabolic pathways altered in cancer cells 350
The NF-Y/p53 liaison: Well beyond repression. 349
Alternative splicing of transcription factors genes in muscle physiology and pathology 346
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 336
Dissection of the NF-Y transcriptional activation potential 335
Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2 334
Cloning and characterization of the histone-fold proteins YBL1 and YCL1 333
NF-Y co-associates with FOS at promoters, enhancers, repetitive elements, and inactive chromatin regions, and is stereo-positioned with growth-controlling transcription factors. 329
New curcumin-derived ligands and their affinity towards Ga3+, Fe3+and Cu2+: Spectroscopic studies on complex formation and stability in solution 329
NF-Y loss triggers p53 stabilization and apoptosis in HPV18-positive cells by affecting E6 transcription 328
HSP-CBF is an NF-Y-dependent coactivator of the heat shock promoters CCAAT boxes 325
Structure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking 323
Ternary complex formation between MADS-box transcription factors and the histone fold protein NF-YB 322
Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63 318
The 1,10-phenanthroline ligand enhances the antiproliferative activity of dna-intercalating thiourea-pd(Ii) and-pt(ii) complexes against cisplatin-sensitive and-resistant human ovarian cancer cell lines 317
An acetylation-mono-ubiquitination switch on lysine 120 of H2B 316
DNA damage promotes histone deacetylase 4 nuclear localization and repression of G2/M promoters via p53 C-terminal lysines 314
Dysregulation of NF–Y splicing drives metabolic rewiring and aggressiveness in colon cancer 312
The interplay between NF-Y, AR and lipid metabolism regulates tumor aggressiveness in prostate cancer. 309
Alternative splicing of the transcription factor NF-Y promotes cell migration and invasion in colon cancer 309
Switch of NF-YA splice variants in prostate cancer development and progression 309
Specific inhibition of NF-Y subunits triggers different cell proliferation defects. 302
A specific role for the splice variants of the transcription factor NF-Y in modulating the transcriptional activity of the myogenic program 293
Scouting Sigma Receptor Ligands As New Tools For The Treatment Of Neurodegenerative Diseases And Cancer 290
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting 288
Probing solute–solvent hydrogen bonding with fluorescent water-soluble curcuminoids 286
A non transcriptional role for NF-Y in DNA replication 283
Alterations in NF-Y splicing enable the metabolic plasticity of colon cancer cells and foster dynamic interactions within the tumor niche 282
Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads 276
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 273
Role of the CCAAT-transcription factor NF-Y and its splice variants in myogenic differentiation and muscle regeneration 270
NF-YC complexity is generated by dual promoters and alternative splicing 269
NF-Y LOSS REACTIVATES p53 AND TRIGGERS p53-DEPENDENT APOPTOSIS IN HPV-POSITIVE HUMAN CERVICAL CARCINOMA CELLS 261
Dynamic recruitment of transcription factors and epigenetic changes on the ER stress response gene promoters 259
Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates 258
The transcription factor NF-Y participates to stem cell fate decision and regeneration in adult skeletal muscle 258
Development of new metal-chelating multi target drus derived from Curcumin 252
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 250
Direct non transcriptional role of the CCAAT-factor NF-Y in DNA replication 250
The NF-YA Splicing Signature Controls Aggressiveness of Colon Cancer by Regulating Cell Metabolism and Different Types of Cell Migration 247
Role of the transcriprion factor NF-Y in cell cycle regulation 247
The NF-YA splicing signature controls aggressiveness of colon cancer by regulating different modes of cell migration and cell metabolism. 241
Monitoring DNA Hybridization with Organic Electrochemical Transistors Functionalized with Polydopamine 240
Development of new therapeutic Metal(III)-chelating agents derived from Curcumin 238
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells 233
Bridging pyrimidine hemicurcumin and Cisplatin: Synthesis, coordination chemistry, and in vitro activity assessment of a novel Pt(II) complex 224
The transcription factor NF-Y is required for satellite stem cell proliferation and skeletal muscle tissue repair 223
DNA damage promotes HDAC4 nuclear localization and G2/M promoters repression via p53 C-terminal lysisnes 222
Development of new metal-based phyto-radiopharmaceuticals: diagnostic agents derived from Cur(e)cumin 219
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 219
The NF–Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer 218
Understanding the molecular mechanisms of Curcumin derivatives chemotherapic activity 218
Development of Stable Amino-Pyrimidine–Curcumin Analogs: Synthesis, Equilibria in Solution, and Potential Anti-Proliferative Activity 216
Expression of the CCAAT-binding factor NF-Y in Caenorhabditis elegans 216
Investigation of transcription factor–DNA binding with electrolyte-gated organic transistors 203
Cell cycle regulation of NF-YC nuclear localization 200
In situ immunofluorescent staining of autophagy in muscle stem cells 196
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 189
Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism 187
Deciphering the transcriptional network of NF-Y in prostate cancer development and progression 184
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 176
Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation 155
Histone Marks-Dependent Effect on Alternative Splicing: New Perspectives for Targeted Splicing Modulation in Cancer? 151
The transcription factor NF-Y participates in prostate cancer progression and response to androgen-deprivation therapy 146
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 141
The transcription factor NF-Y is required for satellite stem cell myogenic progression and skeletal muscle tissue repair 134
Cross-talk between NF-Y transcription factor and m6A epitanscriptomic regulators in colon cancer: molecular characterization and clinical relevance. 133
Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function 124
The NF–Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer 116
The role(s) of NF-Y in development and differentiation 97
Targeting monocarboxylate transporter 1 with a copper-chelating coumarin-based bioconjugate: Synthesis and characterization 82
Correction: Investigation of transcription factor-DNA binding with electrolyte-gated organic transistors (J. Mater. Chem. C (2024) 12 (7596–7604) DOI: 10.1039/D4TC00260A) 79
Metabolic reprogramming controlled by NF-YA alternative splicing creates therapeutic opportunities in colorectal cancer 17
MXene‐Based Conductive Micropatterned Composites Promote Myogenic Differentiation of Muscle Cells 13
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer 7
null 4
Totale 25.326
Categoria #
all - tutte 87.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021161 0 0 0 0 0 0 0 0 0 0 0 161
2021/20221.672 78 147 175 113 75 111 101 72 202 135 297 166
2022/20231.960 199 260 125 173 202 246 56 182 204 52 153 108
2023/20241.647 60 75 101 151 295 133 244 135 28 65 135 225
2024/20254.889 146 54 203 323 880 759 434 297 469 271 500 553
2025/20268.796 610 385 684 1.068 1.365 589 1.006 391 855 860 537 446
Totale 25.326